Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

The US is making plans to try to intercept a fleeing oil tanker that Russia has claimed jurisdiction over, according to four people familiar with the matter, setting up a possible confrontation ...

The CIA conducted the first known U.S. attack on Venezuelan territory when it carried out a drone strike on a port facility in Venezuela last week, a government official familiar with the operation ...

3I/ATLAS has passed its closest point to Earth, meaning we will soon lose sight of it for good. Some scientists want to send a spacecraft to chase down the alien comet — or the next interstellar ...

Once again, Israeli bombs rained down on Gaza. The latest wave of strikes killed more than 100 people, mostly women and children, according to health authorities. The bombardment marked the deadliest ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

Three Russian MiG-31 Foxhound fighters violated Estonian airspace, prompting the scramble of two Italian F-35s to intercept them. Three MiG-31 Foxhound fighters of the Russian Aerospace Forces entered ...

NATO jets intercepted two Russian SU-30 warplanes carrying supersonic missiles over the Baltic Sea as Vladimir Putin continues to taunt the West with aggressive shows of Moscow's military strength.

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.